Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 avr. 2023 12h00 HE | Source: SPHERICAL INSIGHTS LLP

Global Acute Respiratory Distress Syndrome Market Size To Exceed USD 2137.6 Billion By 2030 | CAGR of 7.9%

New York, United States , April 03, 2023 (GLOBE NEWSWIRE) -- The Global Acute Respiratory Distress Syndrome Market Size to grow from USD 980.4 million in 2021 to USD 2,137.6 million by 2030, at a...
04 août 2020 08h00 HE | Source: Arch Biopartners

Arch Biopartners Receives Independent Institutional Review Board Approval for Phase II Trial for LSALT Peptide

TORONTO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received independent Institutional Review...
23 avr. 2020 16h54 HE | Source: Arch Biopartners

Arch Biopartners Submits Application to Health Canada to Conduct COVID19 Phase II Human Trial for Metablok to Prevent Lung and Kidney Inflammation

TORONTO, April 23, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) a clinical stage company developing new drug candidates for treating...